Nicotinamide treatment in the prevention of insulin‐dependent diabetes mellitus

This publication has 75 references indexed in Scilit:

• Nicotinamide and 3-aminobenzamide inhibit recombinant human interferon-γ-induced HLA-DR antigen expression, but not HLA-A, B, C antigen expression, on cultured human thyroid cells
  Clinical Endocrinology, 1992
• Double-Blind Randomized Trial of Nicotinamide on Early-Onset Diabetes
  Diabetes Care, 1992
• Inhibition of insulin secretion by interleukin‐1β and tumour necrosis factor‐α via an L‐arginine‐dependent nitric oxide generating mechanism
  FEBS Letters, 1990
• A Preliminary Multicentre Study of the Treatment of Recently Diagnosed Type 1 Diabetes by Combination Nicotinamide-Cyclosporin Therapy
  Diabetic Medicine, 1990
• Nicotinamide Increases C-peptide Secretion in Patients with Recent Onset Type 1 Diabetes
  Diabetic Medicine, 1989
• High Dose Nicotinamide Fails to Prevent Diabetes in BB Rats
  Autoimmunity, 1989
• STIMULATION OF CELL REPLICATION IN TRANSPLANTED PANCREATIC ISLETS BY NICOTINAMIDE TREATMENT
  Transplantation, 1988
• Effect of niacin/nicotinamide deficiency on the diabetogenic effect of streptozotocin
  Cellular and Molecular Life Sciences, 1988
• NICOTINAMIDE MAY EXTEND REMISSION PHASE ININSULIN-DEPENDENT DIABETES
  The Lancet, 1987
• Reactions to niacinamide
  Journal of the American Academy of Dermatology, 1981